1887
  1. Home
  2. Eurosurveillance
  3. Volume 21, Issue 22, 02/Jun/2016
  4. Article
News Open Access
Like 0
Download
Preview this article:
Preview Magnify
Zoom in
Zoomout

European Medicines Agency publishes draft advice on the use of colistin products in animals, for consultation, Page 1 of 1

| /docserver/preview/fulltext/eurosurveillance/21/22/eurosurv-21-22-6-1.gif

There is no abstract available for this article.
Use the preview function to the left.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2016.21.22.30246
2016-06-02
2020-07-09
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2016.21.22.30246
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/21/22/eurosurv-21-22-6.html?itemId=/content/10.2807/1560-7917.ES.2016.21.22.30246&mimeType=html&fmt=ahah

References

  1. The European Medicines Agency (EMA). Updated advice on the use of colistin products in animals within the European Union: development of resistance and possible impact on human and animal health EMA/231573/2016. London: EMA; 26 May 2016. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2016/05/WC500207233.pdf
  2. Skov RL, Monnet DL. Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfolds. Euro Surveill. 2016;21(9):30155.  https://doi.org/10.2807/1560-7917.ES.2016.21.9.30155 
Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error